12.2021: German DETAX, the leading specialist for medical polymer materials with appr. 110 employees, resolves ownership succession in form of a management buy-out. An consortium consisting of funds managed by ECM Equity Capital Management GmbH (“ECM”), PINOVA Capital GmbH (“PINOVA”) and Gilde Healthcare (“Gilde Healthcare Private Equity”) (together the “Investor Consortium”) has acquired a majority stake in DETAX Group. The two long-term managing directors, Mrs. Ursula Juretzki-Mangold and Mr. Ralf König, have invested alongside the Investor Consortium as part of the transaction. After more than 65 years of ownership, the transition from the owner family Regneri to the new owners has been completed. Together with the Investor Consortium, the management team will continue the successful development and will lead DETAX into the next growth phase.
As a specialist in polymer materials, DETAX offers its customers a comprehensive product portfolio of dental and otoplastic consumables. The group serves an international, broadly diversified and loyal customer base. End users of the products include dental practices, dental laboratories as well as audiologists and audio laboratories. The group operates in a non-cyclical, highly regulated market environment. Complying with such regulation, DETAX holds all relevant MDR certificates. This makes DETAX one of the first companies in the industry with an extensive MDR-certified product portfolio. The transaction is subject to merger control approvals and financial details are not disclosed.
Centum Capital provides this public information as a market news, but has not been involved in this transaction.